3 active not recruiting, 2 terminated. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 3, Terminated 1 |
| Phase 1 | 2 | Terminated 2 |
Follow Fusion Pharmaceuticals Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FPI-2265 (225Ac-PSMA-I&T) and Olaparib for Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) FPI-2265, Olaparib - Metastatic Castration-resistant Prostate Cancer | Phase 2 | Active not recruiting | Fusion Pharmaceuticals Inc. | 85 | 2025-02-26 | 2026-10-06 |
| FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) FPI-2265 - Metastatic Castration-resistant Prostate Cancer | Phase 2 | Active not recruiting | Fusion Pharmaceuticals Inc. | 110 | 2024-03-05 | 2026-04-08 |
| A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours [225Ac]-FPI-1966, [111In]-FPI-1967, vofatamab - Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | Terminated | Fusion Pharmaceuticals Inc. | 6 | 2022-04-20 | 2023-12-19 |
| Targeted Alpha Therapy With 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of Castration-resISTant Prostate Cancer (TATCIST). FPI-2265 - Metastatic Castration Resistant Prostate Cancer | Phase 2 | Active not recruiting | Fusion Pharmaceuticals Inc. | 115 | 2021-12-16 | 2026-04-03 |
| A Phase 1 Study of [225Ac]-FPI-1434 Injection [111In]-FPI-1547 Injection, [225Ac]-FPI-1434 Injection multi-dose, FPI-1175 Infusion - Advanced Solid Tumours, Endometrial Cancer | Phase 1 | Terminated | Fusion Pharmaceuticals Inc. | 78 | 2019-01-17 | 2026-01-07 |
Breast Neoplasms (2) · Ovarian Neoplasms (2) · Squamous Cell Carcinoma of Head and Neck (2) · Adrenocortical Carcinoma (1) · Colorectal Neoplasms (1) · Endometrial Neoplasms (1) · Liver Neoplasms (1) · Lung Neoplasms (1) · Stomach Neoplasms (1) · Triple Negative Breast Neoplasms (1) · Urinary Bladder Neoplasms (1) · Uterine Cervical Neoplasms (1) · Uveal Melanoma (1)
United States (4) · Australia (3) · Canada (1)
Julia Kazakin, MD (2) · Charlotte Hawkins, MPH, CCRP, PMP (1) · Dipti Shoop (1) · Keith Barnett (1)